Nomura Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Nomura Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-610,900	Closed	-$19.1M	–	2111
2025 Q4	$19.1M	Buy	610,900 +462,400	+311%	+$11.4M	0.03%	330
2025 Q3	$3M	Buy	148,500 +86,000	+138%	+$1.51M	﹤0.01%	978
2025 Q2	$1.05M	Buy	+62,500	New	+$1.01M	﹤0.01%	986
2025 Q1	–	Sell	-437,500	Closed	-$9.64M	–	2361
2024 Q4	$9.64M	Buy	+437,500	New	+$7.96M	0.01%	519
2023 Q3	–	Sell	-287,000	Closed	-$2.16M	–	1636
2023 Q2	$2.16M	Buy	+287,000	New	+$2.33M	0.01%	702
2023 Q1	–	Sell	-670,000	Closed	-$6.11M	–	1715
2022 Q4	$6.11M	Hold	670,000	–	–	0.03%	435
2022 Q3	$5.41M	Buy	+670,000	New	+$5.92M	0.02%	529
2018 Q3	–	Sell	-300,000	Closed	-$5.69M	–	1500
2018 Q2	$5.69M	Buy	+300,000	New	+$6.12M	0.02%	480
2018 Q1	–	Sell	-150,000	Closed	-$2.85M	–	1670
2017 Q4	$2.85M	Hold	150,000	–	–	0.01%	777
2017 Q3	$2.64M	Buy	+150,000	New	+$3.38M	0.01%	764
2016 Q4	–	Sell	-318,000	Closed	-$14.6M	–	1645
2016 Q3	$14.6M	Sell	318,000 -382,000	-55%	-$19.9M	0.04%	222
2016 Q2	$35.2M	Buy	+700,000	New	+$37.3M	0.11%	96
2015 Q1	–	Sell	-2,125,000	Closed	-$107M	–	2250
2014 Q4	$107M	Buy	2,125,000 +125,000	+6%	+$6.96M	0.29%	52
2014 Q3	$101M	Buy	2,000,000 +1,920,000	+2,400%	+$102M	0.27%	67
2014 Q2	$4.19M	Sell	80,000 -64,700	-45%	-$3.31M	﹤0.01%	762
2014 Q1	$7.59M	Buy	+144,700	New	+$6.69M	﹤0.01%	574

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nomura Holdings's TEVA Position: Q2 2026 in Review

Nomura Holdings reduced its Teva Pharmaceuticals (TEVA) stake by 52% in Q2 2026, selling an estimated $40.4M and leaving 1,124,772 shares worth $38.1M. The position accounts for 0.04% of the portfolio, ranked #232.

Nomura Holdings first reported a position in TEVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $75.9M in Q3 2014. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Nomura Holdings held 1,124,772 shares of Teva Pharmaceuticals worth $38.1M as of Q2 2026.
Nomura Holdings sold 1,213,830 Teva Pharmaceuticals shares in Q2 2026, an estimated $40.4M.
Teva Pharmaceuticals made up 0.04% of Nomura Holdings's portfolio in Q2 2026, its #232 holding.
Nomura Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
Nomura Holdings's Teva Pharmaceuticals position peaked at $75.9M in Q3 2014.
676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.